Alexion Pharmaceuticals, Inc.

Q2 2015 13F Holders

Symbol
ALXN
CUSIP
015351109
Type
Equity
Class
COM
Num filings
595
Total reported value, excl. options
$39.8 B
Manager Report Date Value ($000) Shares Option Type